All lobbying filings

ALB Solutions

ALB Solutions filed a Q4 report for Boehringer Ingelheim Pharmaceuticals, Inc. on January 18, 2026, reporting $40,000 in lobbying income.

Lobbying for Boehringer Ingelheim Pharmaceuticals, Inc. · Pharmaceutical company.

As filed: ALB SOLUTIONS for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

All filings by ALB Solutions · Everything Boehringer Ingelheim Pharmaceuticals, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Lobbyists on this filing 2

ADAM BUCKALEW

Previously held: Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg Harper (R-MS)
VERONICA JACKSON

Previously held: Director, Strategic Planning, Office of the Assistant Secretary for Public Affairs, HHS

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.